Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -134.5% | -49.0% | 1 / 3 | +7.0% | +1.10 pp | -42.59 pp | +1.1% | 0.57 | 51.73 | 79,8 | +7,0% | −6,2 | −124,0% | 51.73 | -11.28 | — |
| Pts | 0 | 0 | 4 | 0 | 8 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 12.100 (close price on 2026-10-13)EPS (TTM): 233,9
Financial charts
1.Revenue & growth
VND bn79,8Q2/26
1.Revenue & growth
VND bn79,8Q2/26
2.Profit & growth
VND bn-8,04Q2/26
3.Profit mix (Penman)
VND bn27,2Q2/26
4.Margins & cost structure
%4.6%Q2/26
5.Returns & cash cycle
% · days-1.8%Q2/26
6.Earnings quality & cash
VND bn-105Q2/26
7.Asset structure
VND bn2.858Q2/26
8.Funding & debt health
VND bn · times2.858Q2/26
9.Revenue backlog
VND bn0,95Q2/26
10.Valuation
times · %51,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-125Q2/26
Adjusted EPS growth, latest quarter
-134%
Average adjusted EPS growth, 3 quarters
-114%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26